Health Care & Hospital Law,
Antitrust & Trade Reg.
Oct. 21, 2024
$2.8 billion settlement signals a new era for health care competition
The settlement includes provisions for BCBS to change its business practices to foster competition and improve transparency. This case sets a precedent for other insurers, signaling stricter enforcement of antitrust laws.
Jennifer Paley
Legal Writer/Journalist and Attorney
In a significant development in the healthcare industry, Blue Cross Blue Shield (BCBS), one of the largest health insurance companies in the United States, has agreed to pay $2.8 billion to settle antitrust class action claims. This landmark decision arises from accusations that the insurance giant engaged in anti-competitive practices that harmed both consumers and healthcare providers.
The origins of the lawsuit trace back to 2020 when a group of BCBS ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In